The Methylation Balance Ratio compares four methylated metabolites (including SAM) to four un-methylated metabolites (including SAH). Therefore, the Methylation Balance Ratio can be thought of as an expanded SAM/ SAH ratio.
The four methyl group donors that make up the numerator of the equation are:
- SAM,
- methionine,
- betaine,
- and serine.
The four un-methylated metabolites are:
- SAH,
- homocysteine,
- DMG,
- and sarcosine.
The clinical utility of the Methylation Balance Ratio is that it represents a potential way to detect methylation imbalance prior to alterations in the SAM/SAH ratio. The SAM/SAH ratio is resistant to fluctuations due to multiple feedback mechanisms and backup pathways. Therefore, measuring the metabolites of these backup pathways may provide earlier insight into subtle fluctuations in methylation balance. This approach is still novel and is based solely on biochemical pathway analysis. However, early Genova data analysis of this biomarker has demonstrated its ability to distinguish a healthy cohort from an unqualified cohort.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.